article thumbnail

Forgotten IVC Filters Aren’t SAFE

CardiacWire

Out of SAFE-IVC’s roughly 270k Medicare beneficiaries, only 15% had their IVC filters retrieved within 1.2 Patients who didn’t have their IVC filters removed had significant rates of filter-related complications (1.4%), caval thrombosis (2.2%), DVT hospital visits (9.2%), and new deep vein thrombosis (21.2%). years of insertion.

article thumbnail

Racial Disparities in Long-Term Outcomes After Endovascular Aortic Aneurysm Repair in Black and White Medicare Beneficiaries

Circulation

Using a 100% sample of national Medicare data, we identified beneficiaries 66 years of age who underwent intact infrarenal endovascular aortic aneurysm repair. The primary outcome was a composite of endovascular or open aortic reintervention, late aneurysm rupture, and all-cause mortality.

article thumbnail

Philips launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction

DAIC

It enrolled 162 subjects at 30 centers with three patient populations – non-thrombotic iliac vein lesion (NIVL), post-thrombotic syndrome (PTS) and acute deep vein thrombosis (aDVT). Current and future burden of venous thrombosis: Not simply predictable. J Thromb Haemost 2014; 12: 1580–90. 2] Scheres LJJ, Lijfering WM, Cannegieter SC.

Stent 105
article thumbnail

From the Member Sections | Tackling the Polypharmacy Pandemic in CV Care

American College of Cardiology

Initiatives such as the World Health Organization's "Medication Without Harm" and the Centers for Medicare and Medicaid Services' (CMS) expanded quality measures aim to reduce preventable emergency visits and hospital admissions due to medication-related harm.

article thumbnail

Abstract 129: Endovascular Therapy in Cerebral Venous Thrombosis: Nationwide Insights and Implications for Mortality

Stroke: Vascular and Interventional Neurology

IntroductionCerebral Venous Thrombosis (CVT) is a rare cerebrovascular condition causing death or functional dependency in 10‐15%. Individuals with Medicare (OR: 0.39, 95% CI: 0.26‐0.59, Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. 0.48, p=0.001), CNS cancer (OR: 0.24, 95% CI: 0.06‐0.93,